The results from the LPS-induced endotoxemia study demonstrate that the co-formulation of HSPB5 with methylprednisolone can provide enhanced anti-inflammatory effects, even in the face of a potent and acute inflammatory insult. This evidence concerns the gene CRYAB and serum lipopolysaccharide activity.